banner
Toll-like receptor agonist Resiquimod, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ625

Toll-like receptor agonist Resiquimod, Purity ≥98%

Synonym: Resiquimod; 144875-48-9; 1-(4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol; R-848; 1-[4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol; Toll-like receptor agonist

  • MDL: MFCD00937759
  • CAS Number: 144875-48-9
  • Compound CID: 159603
img
Product Size
25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Resiquimod, soluble in DMSO and warmed ethanol and insoluble in water, is a potent and selective active small molecule agonist of a Toll-like receptor. It targets TLR7 and TLR8.
Molecular Weight
314.38
Molecular Formula
C17H22N4O2
Targets
TLR7; TLR8
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 62 mg/mL (197.21 mM); Water: Insoluble; Warmed ethanol: 21 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
Resiquimod is used to stimulate immune responses via TLR7 and TLR8, making it relevant in vaccine adjuvant research and studies on antiviral immunity.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0